Krystal Biotech Balance Sheet Health
Financial Health criteria checks 6/6
Krystal Biotech has a total shareholder equity of $799.2M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $853.3M and $54.1M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$538.26m |
Equity | US$799.24m |
Total liabilities | US$54.05m |
Total assets | US$853.30m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 4KB's short term assets ($602.2M) exceed its short term liabilities ($47.6M).
Long Term Liabilities: 4KB's short term assets ($602.2M) exceed its long term liabilities ($6.5M).
Debt to Equity History and Analysis
Debt Level: 4KB is debt free.
Reducing Debt: 4KB had no debt 5 years ago.
Debt Coverage: 4KB has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 4KB has no debt, therefore coverage of interest payments is not a concern.